The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or fall in the future. Viking Therapeutics Inc shares valued at $1,345,500 were sold by Lian Brian on Feb 09 ’24. At $29.90 per share, Lian Brian sold 45,000 shares. The insider’s holdings dropped to 2,139,882 shares worth approximately $151.65 million following the completion of this transaction.
Also, Lian Brian sold 269,079 shares, netting a total of over 7,230,784 in proceeds. Following the sale of shares at $26.87 each, the insider now holds 2,184,882 shares.
Before that, Rouan Sarah Kathryn had sold 25,000 shares from its account. In a trade valued at $701,250, the Director traded Viking Therapeutics Inc shares for $28.05 each. Upon closing the transaction, the insider’s holdings decreased to 25,000 shares, worth approximately $0.0.
As published in a research note from Oppenheimer on March 26, 2024, Viking Therapeutics Inc [VKTX] has been retained to an Outperform and the price target has been revised to $138. Analysts at Jefferies started covering the stock with ‘”a Buy”‘ outlook in a report released in early March. As of February 28, 2024, Oppenheimer has reiterated its “an Outperform” rating for VKTX.
Analyzing VKTX Stock Performance
During the last five days, there has been a drop of approximately -3.81%. Over the course of the year, Viking Therapeutics Inc shares have jumped approximately 280.82%. Shares of the company reached a 52-week high of $99.41 on 02/28/24 and a 52-week low of $17.23 on 01/03/24. A 50-day SMA is recorded $59.39, while a 200-day SMA reached $25.89. Nevertheless, trading volume fell to 1.74 million shares from 2.58 million shares the previous day.
Support And Resistance Levels for Viking Therapeutics Inc (VKTX)
According to the 24-hour chart, there is a support level at 70.26, which, if violated, would cause prices to drop to 69.66. In the upper region, resistance lies at 71.60. The next price resistance is at 72.34. RSI (Relative Strength Index) is 50.63 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at -4.04, which suggests the price will decrease in the coming days. Percent R is at 87.64%, indicating bearish price movement. Stochastics %K at holding indicates that the stock is to be held.
Is Viking Therapeutics Inc subject to short interest?
Stocks of Viking Therapeutics Inc saw a sharp steep in short interest on Mar 15, 2024 dropping by -0.88 million shares to 11.14 million. Data from Yahoo Finance shows that the short interest on Feb 15, 2024 was 12.02 million shares. A decline of -7.9% in short interest reflects a positive sentiment towards the stock. Despite the fact that short shares comprise just 0.93 of the overall float, the days-to-cover ratio (short ratio) decline to 0.93.
